TMCnet News
Primary Myelofibrosis Forecast in 8 Major Markets 2016-2026 - Research and MarketsResearch and Markets has announced the addition of the "Primary Myelofibrosis Forecast in 8 Major Markets 2016-2026" report to their offering. This report provides the current prevalent population for PMF across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight, several of the main symptoms and co-morbidities of PMF have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for PMF include:
Reason to buy:
Key Topics Covered: 1. Introduction 2. Cause of the Disease 3. Risk Factors & Prevention 4. Diagnosis of the Disease 5. Variation by Geography/Ethnicity 6. Disease Prognosis (News - Alert) & Clinical Course 7. Key Co-morbid Conditions/Features Associated with the Disease 8. Methodology for Quantification of Patient Numbers 9. Top-Line Prevalence for Primary Myelofibrosis 10. Features of PMF Patients 11. Abbreviations used in the Report 12. Patient-Based Offering 13. Online Pricing Data and Platforms For more information visit http://www.researchandmarkets.com/research/8hf6s2/primary View source version on businesswire.com: http://www.businesswire.com/news/home/20160419006703/en/ |